login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NUCANA PLC-ADR (NCNA) Stock News
USA
- NASDAQ:NCNA -
US67022C3043
-
ADR
3.41
USD
-0.08 (-2.29%)
Last: 11/14/2025, 8:09:09 PM
3.42
USD
+0.01 (+0.29%)
After Hours:
11/14/2025, 8:09:09 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NCNA Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: NuCana plc
NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
2 days ago - By: NuCana plc
NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
11 days ago - By: NuCana plc
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
11 days ago - By: NuCana plc
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
2 months ago - By: NuCana plc
NuCana Compliant with All Nasdaq Continued Listing Criteria
2 months ago - By: NuCana plc
NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
3 months ago - By: NuCana plc
NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: NuCana plc
NuCana Announces ADS Ratio Change
25 days ago - By: Benzinga
- Mentions:
IBIO
NERV
ADTX
RANI
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
a month ago - By: Benzinga
- Mentions:
ADXN
OLMA
DCTH
RANI
...
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
a month ago - By: NuCana plc
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
a month ago - By: NuCana plc
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
4 months ago - By: NuCana plc
NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
a month ago - By: NuCana plc
NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy
2 months ago - By: NuCana plc
NuCana Compliant with All Nasdaq Continued Listing Criteria
2 months ago - By: NuCana plc
NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
3 months ago - By: NuCana plc
NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: NuCana plc
NuCana Announces ADS Ratio Change
4 months ago - By: NuCana plc
NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
Please enable JavaScript to continue using this application.